Literature DB >> 1377225

Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin.

A K Nussler1, M Di Silvio, T R Billiar, R A Hoffman, D A Geller, R Selby, J Madariaga, R L Simmons.   

Abstract

Nitric oxide (NO) is a short-lived biologic mediator that is shown to be induced in various cell types and to cause many metabolic changes in target cells. Inhibition of tumor cell growth and antimicrobial activity has been attributed to the stimulation of the inducible type of the NO synthase (NOS). However, there is limited evidence for the existence of such inducible NOS in a human cell type. We show here the induction of NO biosynthesis in freshly isolated human hepatocytes (HC) after stimulation with interleukin 1, tumor necrosis factor (TNF), IFN-gamma, and endotoxin. Increased levels of nitrite (NO2-) and nitrate (NO3-) in culture supernatants were associated with NADPH-dependent NOS activity in the cell lysates. The production of NO2- and NO3- was inhibited by NG-monomethyl L-arginine and was associated with an increase in cyclic guanylate monophosphate release. The data presented here provide evidence for the existence of typical inducible NO biosynthesis in a human cell type.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1377225      PMCID: PMC2119287          DOI: 10.1084/jem.176.1.261

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  20 in total

1.  Modulation of nitrogen oxide synthesis in vivo: NG-monomethyl-L-arginine inhibits endotoxin-induced nitrate/nitrate biosynthesis while promoting hepatic damage.

Authors:  T R Billiar; R D Curran; B G Harbrecht; D J Stuehr; A J Demetris; R L Simmons
Journal:  J Leukoc Biol       Date:  1990-12       Impact factor: 4.962

2.  Multiple cytokines are required to induce hepatocyte nitric oxide production and inhibit total protein synthesis.

Authors:  R D Curran; T R Billiar; D J Stuehr; J B Ochoa; B G Harbrecht; S G Flint; R L Simmons
Journal:  Ann Surg       Date:  1990-10       Impact factor: 12.969

Review 3.  Does endothelium-derived nitric oxide have a role in cytokine-induced hypotension?

Authors:  C F Nathan; D J Stuehr
Journal:  J Natl Cancer Inst       Date:  1990-05-02       Impact factor: 13.506

Review 4.  Role of nitric oxide synthesis in macrophage antimicrobial activity.

Authors:  C F Nathan; J B Hibbs
Journal:  Curr Opin Immunol       Date:  1991-02       Impact factor: 7.486

5.  Nitrogen oxide levels in patients after trauma and during sepsis.

Authors:  J B Ochoa; A O Udekwu; T R Billiar; R D Curran; F B Cerra; R L Simmons; A B Peitzman
Journal:  Ann Surg       Date:  1991-11       Impact factor: 12.969

6.  Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock.

Authors:  A Petros; D Bennett; P Vallance
Journal:  Lancet       Date:  1991 Dec 21-28       Impact factor: 79.321

7.  Human colorectal adenocarcinoma cells: differential nitric oxide synthesis determines their ability to aggregate platelets.

Authors:  M W Radomski; D C Jenkins; L Holmes; S Moncada
Journal:  Cancer Res       Date:  1991-11-15       Impact factor: 12.701

8.  Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates.

Authors:  M Denis
Journal:  J Leukoc Biol       Date:  1991-04       Impact factor: 4.962

9.  NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide.

Authors:  R G Kilbourn; S S Gross; A Jubran; J Adams; O W Griffith; R Levi; R F Lodato
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

10.  An L-arginine-dependent mechanism mediates Kupffer cell inhibition of hepatocyte protein synthesis in vitro.

Authors:  T R Billiar; R D Curran; D J Stuehr; M A West; B G Bentz; R L Simmons
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

View more
  87 in total

1.  Isolation and characterization of a human hepatic epithelial-like cell line (AKN-1) from a normal liver.

Authors:  A K Nussler; G Vergani; S M Gollin; K Dorko; S M Morris; A J Demetris; M Nomoto; H G Beger; S C Strom
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999-04       Impact factor: 2.416

Review 2.  Nitric oxide and bone.

Authors:  R J van't Hof; S H Ralston
Journal:  Immunology       Date:  2001-07       Impact factor: 7.397

Review 3.  Autonomic regulation of neuroimmunological responses: implications for multiple sclerosis.

Authors:  E M Frohman; N L Monson; A E Lovett-Racke; M K Racke
Journal:  J Clin Immunol       Date:  2001-03       Impact factor: 8.317

Review 4.  Nitric oxide in patients with cirrhosis and bacterial infections.

Authors:  José Such; Rubén Francés; Miguel Pérez-Mateo
Journal:  Metab Brain Dis       Date:  2002-12       Impact factor: 3.584

5.  Altered immune response of interferon regulatory factor 1-deficient mice against Plasmodium berghei blood-stage malaria infection.

Authors:  R S Tan; C Feng; Y Asano; A U Kara
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

6.  Hepatic nitric oxide generation as a putative mechanism for failure of intrahepatic islet cell grafts.

Authors:  A K Nussler; P B Carroll; M Di Silvio; H L Rilo; R L Simmons; T E Starzl; C Ricordi
Journal:  Transplant Proc       Date:  1992-12       Impact factor: 1.066

7.  Mice deficient in interleukin-4 (IL-4) or IL-4 receptor alpha have higher resistance to sporozoite infection with Plasmodium berghei (ANKA) than do naive wild-type mice.

Authors:  Michael Saeftel; Andreas Krueger; Sandra Arriens; Volker Heussler; Paul Racz; Bernhard Fleischer; Frank Brombacher; Achim Hoerauf
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

8.  Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death.

Authors:  V E Laubach; E G Shesely; O Smithies; P A Sherman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

9.  In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases.

Authors:  H Koprowski; Y M Zheng; E Heber-Katz; N Fraser; L Rorke; Z F Fu; C Hanlon; B Dietzschold
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

10.  Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes.

Authors:  D A Geller; C J Lowenstein; R A Shapiro; A K Nussler; M Di Silvio; S C Wang; D K Nakayama; R L Simmons; S H Snyder; T R Billiar
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.